Madrid (Spain) 19/05/2016 – ESO, CNIO and NRCO Conference on Familial Cancer
ESO, CNIO and NRCO Conference on Familial Cancer 19/05/2016 – 20/05/2016, Madrid, Spain Chairs: R. Eeles, UK – W.D. Foulkes, CA – M. Robledo, ES – H. Vasen, NL The ESO, CNIO and NRCO Conference on...
View ArticleDoctors and nurses: We work as a team – why not train as a team?
Mr Lloyd is angry! His elderly mother is getting no treatment for her metastatic lung cancer, and he doesn’t want to hear what the doctors and nurses are saying… …A different approach by a new face....
View ArticleMilan (Italy), 25-27/11 – ESO-ESMO-RCE Clinical Update on Rare Adult Solid...
Any educational effort in the rare cancer area makes little sense if disconnected from a networking environment.Thus, this Course will be first offered to clinical oncologists involved into the...
View ArticleActive surveillance: the search for greater certainty
Delaying treatment for a curable prostate cancer is an increasingly popular option among men with low risk tumours. Simon Crompton looks at efforts to learn more about who benefits and how to avoid...
View ArticleAscona (Switzerland) 10-13/06/2017 – Leukaemia and Lymphoma
The programme is designed for postgraduate medical doctors at any stage of clinical career who are interested in haematological oncology. A mix of experienced clinicians or pathologists etc., and...
View ArticleBoston (USA) 15-7-2017 – Breast Cancer in Young Women: Joint DFCI-ESO Symposium
The first edition of the Joint “ESO-DFCI Breast Cancer in Young Women Symposium” will be held during the Breast Cancer: New Horizons, Current Controversies Course, on July 15 in Boston, United States....
View ArticleWho’s Who and programmes 2017 – Thirty-five Years of Education in Cancer...
ESO’s brochure “Who’s Who and Programmes 2017” is now available (click on the image to download the pdf). (Click on the image to download the pdf)
View ArticleBiosimilars in oncology: challenges and opportunities
An ESO task force met to discuss the potential for “biosimilar” medical products in oncology, analyzing facts and debunking some myths. Some of the most used biologic drugs in oncology are going off...
View ArticleA man with a vision with the drive to achieve it – Patrick Johnston, medical...
The European School of Oncology has lost a supporter, colleague and friend, writes Mike Clarke, who co-chaired ESO’s Systematic Reviews Masterclass alongside Patrick Johnston. With the sudden and...
View ArticleA is for apple (but not always in Africa)
In many books used for teaching the alphabet to children, the letter A is associated to an apple: the association may seem obvious, but usually it is not so for an African child: in Africa A is not for...
View ArticleThe ESO Masterclass: where those most eager to learn meet those most willing...
The annual week-long course lies at the very heart of ESO’s mission and shapes the oncology leaders of tomorrow. Download full article
View ArticleFedro Peccatori: teaching the world to care
First he was a pupil, then he joined the faculty. Now Fedro Peccatori has taken charge of ESO’s entire educational programme, and he knows exactly where he wants to take it. “There is no difference...
View ArticleTurning more than one page
We at ESO are turning important pages in the history of our service to the European cancer community. We now invite you to turn the pages of Cancer World, which we hope you will find both an...
View ArticleBogotà (Colombia) 27/04/2016 – Masterclass in Clinical Oncology
2nd ESO-ESMO Latin-American Masterclass in Clinical Oncology 27/04/2016 – 01/05/2016, Bogotà, Colombia Chairs: A. Cervantes, ES – N. Pavlidis, GR – R.A. Stahel, CH Scientific Co-ordinators: M.S....
View ArticleCancer surgery: the key factors that influence outcomes
Cancer patients are put at risk unless the surgeons who operate on them understand the principles of the disease, work closely with other oncology disciplines, and know which patients need to be...
View ArticleArt and oncology: one life
Scientist or artist? Michael Peckham, who is best known for his contribution to the treatment of testicular cancer and Hodgkin lymphoma, and was involved in founding the European School of Oncology,...
View ArticleAdvanced Breast Cancer: what’s new in treatment and care?
Despite growing precision in understanding the biology of breast cancer, progress in extending survival of people with metastatic disease remains frustratingly slow. Median survival is only about three...
View Article14.11.2019 – 16.11.2019 – ESO-ESMO Advanced Breast Cancer Fifth International...
Coordinating Chair – Fatima Cardoso Chairs – Eric P. Winer, Larry Norton, Alberto Costa Co-Chairs – Giuseppe Curigliano, Shirley A. Mertz The International Consensus Conference for Advanced Breast...
View ArticleCancer patients advocates train up fellow activists across Europe
Cancer patient advocates from 26 European countries, active across a wide spectrum of cancer types, spent four days last week at the first training course to be developed and run by advocates...
View Article
More Pages to Explore .....